Open biotechnology: licenses needed

Open biotechnology may be the ideal solution to ensure scientific progress and the realization of the common good, but it has yet to deliver on its promises.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Boyle, J. in Perspectives on Properties of the Human Genome Project (ed. Kieff, F.S.) 97 (Elsevier Academic Press, St. Louis, USA 2003).

  2. 2

    Heller, M.A. & Eisenberg, R.S. Science 280, 698–701 (1998).

  3. 3

    Merges, R.P. & Nelson, R. Columbia Law Rev. 90, 839–916 (1990).

  4. 4

    Kass, L. Toward a More Natural Science (Free Press, New York, 1985).

  5. 5

    Kass, L. Public Interest 107, 65–86 (1992).

  6. 6

    Greenfield, D. Santa Clara Comput. High Technol. Law J. 25, 467–538 (2009).

  7. 7

    Caulfield, T., Cook-Deegan, R.M., Kieff, F.S. & Walsh, J.P. Nat. Biotechnol. 24, 1091–1094 (2006).

  8. 8

    Cho, M.K., Illangasekare, S., Weaver, M.A., Leonard, D.G.B. & Merz, J.F. J. Mol. Diagn. 5, 3–8 (2003).

  9. 9

    Matthijs, G. & Halley, D. Eur. J. Hum. Genet. 10, 783–785 (2002).

  10. 10

    Murray, F. N. Engl. J. Med. 356, 2341–2343 (2007).

  11. 11

    St.-Laurent, A.M. Understanding Open Source and Free Software Licensing, (O'Reilly Publishing, Sebastopol, California, 2004).

  12. 12

    Curry v. Audax, District Court of Amsterdam Case no. 334492/KG 06–176 SR (2006).

  13. 13

    Jacobsen v. Katzer, 535 F.3d 1373 (Fed. Cir. 2008).

  14. 14

    In re: Dane K. Fisher and Rughunath v. Lalgudi 421 F.3d 1365 (Fed Cir. 2005).

  15. 15

    In re: Marek Z. Kubin and Raymond G. Goodwin No. 09–667,859 (Fed. Cir. April 3, 2009).

  16. 16

    US General Accounting Offices. Report to Congressional Requesters (GAO-02–789) (US General Accounting Offices, Washington, DC, 2002).

  17. 17

    Malakoff, D. Science 291, 1194 (2001).

  18. 18

    Guadamuz Gonzàlez, A. NCJL & Tech. 7, 321–366 (2006).

  19. 19

    Data Access Policy for the International HapMap Project (policy no longer in use). http://hapmap.ncbi.nlm.nih.gov/cgi-perl/registration

  20. 20

    Wellcome Trust Case Control Consortium. https://www.wtccc.org.uk/info/access_to_data_samples.shtml

  21. 21

    Cromer, J.D. UMKC Law Rev. 76, 505–523 (2007).

  22. 22

    Birney, E. et al. Nature 461, 168–170 (2009).

  23. 23

    Cottrell, C.R. Wake Forest Intell. Prop. L.J. 7, 251–274 (2007).

Download references

Acknowledgements

The author would like to thank F. Hemmings and B.M. Knoppers for reviewing the manuscript, E.R. Gold for comments on an earlier version of the draft and Genome Canada/Genome Quebec for their financial support of the PRIVAC project Genomics Applied to the Discovery and Development of Vaccines and Immunotherapies.

Author information

Correspondence to Yann Joly.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Joly, Y. Open biotechnology: licenses needed. Nat Biotechnol 28, 417–419 (2010) doi:10.1038/nbt0510-417

Download citation

Further reading